Chris Rozell traveled to Washington, D.C. to share the impacts of the past decade of brain research funded by the NIH BRAIN Initiative with Congress — and share with local representatives how Georgia Tech is playing a key role in leading the charge.
The team used a computational math theory to identify gene-gene interactions that may be good targets for treating basal-like cancers that are resistant to traditional hormone therapies.
Researchers at the Georgia Institute of Technology and the University of Wisconsin-Madison have developed a new vaccine that offers broad protection against not only SARS-CoV-2 variants, but also other bat sarbecoviruses
Three Georgia Tech students who created a pediatric medical device won $15,000 Wednesday night during the 2024 ACC InVenture Prize, an annual undergraduate entrepreneurship competition.
Wearable bio-measurement device could alert people who work outside to dangerous levels of rising body temperature and dehydration that could help avoid heat-related injury.
Georgia Tech chemists are exploring the behavior of a complex protein associated with glaucoma — characterizing one of the largest amyloid-forming proteins to date.
In early 2020, Georgia Tech researchers designed a saliva-based polymerase chain reaction (PCR) test and encouraged community members to test weekly to track the health of the campus.